MAPK1 and melanoma: In melanoma, most of the MAPK1 mutations cluster in the ATP-binding domain or, as for the MAPK2E322K, in the DUSPs-binding domain where the MAPK phosphatases (also known as dual-specificity phosphatases or DUSPs) bind to exert their dephosphorylating activity on ERKs.